Skip to content

Safety and effectiveness of electroacupuncture in the treatment of postoperative gastrointestinal dysfunction in patients with perioperative esophageal cancer: a prospective, randomized, and controlled clinical trial

Safety and effectiveness of electroacupuncture in the treatment of postoperative gastrointestinal dysfunction in patients with perioperative esophageal cancer: a prospective, randomized, and controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000118
Enrollment
Unknown
Registered
2024-07-04
Start date
2024-08-01
Completion date
Unknown
Last updated
2024-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal dysfunction after esophageal cancer surgery

Interventions

Sponsors

The First Affiliated Hospital of Naval Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: The study will include male or female patients of age 18–60 years; those diagnosed as having EC and will be undergoing elective surgery; those with American Society of Anesthesiologists (ASA) classification I–III [33]; those without any previous history of thoracic or abdominal surgery; and those who have signed informed consent.

Exclusion criteria

Exclusion criteria: The study will exclude patients who had received epidural anesthesia, need to undergo other synchronized operations, had received drugs that affect the intestinal function within 1 month before the study, have intraoperative and postoperative complications and require long-term intensive care (more than 24 h), have mental disorder or a history of opioid abuse, (6) had received acupuncture treatment within 1 month before the study, had participated in other clinical studies 3 months before enrolling for this study, have severe hepatic and renal dysfunction, had undergone emergency reoperations, and have second- or third-degree heart blocks and tachyarrhythmias with a baseline heart rate of <50 beats/min or have electrical stimulation devices (pacemakers or implantable defibrillators); those who experience gastrointestinal bleeding before operation (bleeding volume: 800 mL); and those with ASA classification IV or V (IV indicates that the patient has a severe systemic disease that poses an ongoing threat to life; V indicates that the patient is dying and is expected not to survive without surgery).

Design outcomes

Primary

MeasureTime frame
the time of first defecation;

Secondary

MeasureTime frame
Tolerance time for semiliquid and solid foods;Time of first exhaust;Postoperative hospitalization;EQ -5D-5L scoring;Postoperative quality of life;Hospital Anxiety and Depression Scale;I-FEED scoring system;Time of first ambulation;Laboratory test indicators (blood routine, CRP, L-6, IL-10, TNF-a);Demand for postoperative analgesics and defecation medication;

Countries

China

Contacts

Public ContactXiaofeng Zhai

The First Affiliated Hospital of Naval Medical University

zhaixfch@163.com13917595511

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026